Verastem | VSTM - Trade Debtors


Verastem reported $9.01M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
AbbVie USD 12.59B 180M Dec/2025
Alaunos Therapeutics USD 2K 0 Jun/2025
AstraZeneca USD 17.88B 1.17B Mar/2026
Curis USD 2.55M 400K Jun/2024
Cytokinetics USD 6.83M 10.94M Mar/2026
Gilead Sciences USD 4.74B 172M Mar/2026
Incyte USD 1.05B 27.09M Mar/2026
Laboratory Of America USD 2.45B 189.8M Mar/2026
Novartis USD 9.6B 2.69B Mar/2026
Pfizer USD 16.17B 332M Mar/2026
Roche Holding CHF 11.9B 460M Dec/2025
TG Therapeutics USD 392.05M 86.42M Mar/2026
Verastem USD 9.01M 8.81M Dec/2025